What is Equillium Effective Interest Rate on Debt %?
Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Equillium's annualized positive value of Interest Expense for the quarter that ended in Dec. 2024 was $0.00 Mil. Equillium's average total debt for the quarter that ended in Dec. 2024 was $0.44 Mil. Therefore, Equillium's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2024 was 0.00%.
Equillium Effective Interest Rate on Debt % Historical Data
The historical data trend for Equillium's Effective Interest Rate on Debt % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Equillium's Effective Interest Rate on Debt %
For the Biotechnology subindustry, Equillium's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Equillium's Effective Interest Rate on Debt % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Equillium's Effective Interest Rate on Debt % distribution charts can be found below:
* The bar in red indicates where Equillium's Effective Interest Rate on Debt % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data,
the Interest Expense data used here is four times the quarterly (Dec. 2024) interest expense data.
Effective Interest Rate on Debt % is displayed in the 30-year financial page.
Equillium (NAS:EQ) Effective Interest Rate on Debt % Explanation
Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.
Equillium Effective Interest Rate on Debt % Related Terms
Thank you for viewing the detailed overview of Equillium's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.
Equillium Inc is a clinical-stage biotechnology company engaged in developing novel therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. The company intends to commercialize its product candidates either independently or through partnerships, or otherwise monetize its pipeline through strategic transactions. Itolizumab (EQ001), a clinical-stage product candidate, is an anti-CD6 immune-modifying monoclonal antibody, or mAb, that selectively targets the CD6-ALCAM signaling pathway to downregulate pathogenic T effector cells while preserving T regulatory cells critical for maintaining a balanced immune response. The company's other clinical-stage and pre-clinical-stage candidates include EQ101 and EQ302.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
EQ has been successfully added to your 